Occurrence of Sézary syndrome following the initiation of anti-IL-5 treatment

Barré, Mathilde; Amatore, Florent; Avenin, Morgan; Gorvel, Laurent; Olive, Daniel; Delaporte, Emmanuel

Barré, Mathilde; Amatore, Florent; Avenin, Morgan; Gorvel, Laurent; Olive, Daniel; Delaporte, Emmanuel.

Afiliação

Barré M; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique U7258, Aix Marseille Université, Institut Paoli-Calmettes, Marseille, France
Amatore F; Department of Dermatology, Aix Marseille University, Assistance Publique-Hôpitaux de Marseille, Hôpital Nord, Marseille, France
Avenin M; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique U7258, Aix Marseille Université, Institut Paoli-Calmettes, Marseille, France
Gorvel L; Department of Dermatology, Aix Marseille University, Assistance Publique-Hôpitaux de Marseille, Hôpital Nord, Marseille, France
Olive D; Department of Pathology, Institut Paoli-Calmettes, Marseille, France
Delaporte E; Centre de Recherche en Cancérologie de Marseille, INSERM U1068, Centre National de la Recherche Scientifique U7258, Aix Marseille Université, Institut Paoli-Calmettes, Marseille, France

Eur J Dermatol ; 32(3): 419-420, 2022 05 01.

Article em En | MEDLINE | ID: mdl-36065539

Assuntos

Síndrome de Sézary; Neoplasias Cutâneas; Humanos; Síndrome de Sézary/tratamento farmacológico; Neoplasias Cutâneas/induzido quimicamente; Neoplasias Cutâneas/tratamento farmacológico

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Cutâneas / Síndrome de Sézary Limite: Humans Idioma: En Revista: Eur J Dermatol Assunto da revista: DERMATOLOGIA Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google